Subcutaneous versus intramuscular depot methoxyprogesterone acetate: a comparative review

ISSN： 1745-5057

Source： Women's Health, Vol.2, Iss.2, 2006-03, pp. : 191-197

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glatiramer acetate versus interferon Beta-1a for subcutaneous administration: Comparison of outcomes among multiple sclerosis patients

By Castelli-Haley Jane

Advances in Therapy, Vol. 25, Iss. 8, 2008-08 ,pp. : 830-830

Springer Publishing Company

Access to resources Recommend Favorite

Experiences of Women with Depot Medroxyprogesterone Acetate: A Qualitative Study

By Railey M.

Journal of Advancement in Medicine, Vol. 11, Iss. 3, 1998-01 ,pp. : 187-198

Springer Publishing Company

Access to resources Recommend Favorite

Depot medroxyprogesterone acetate contraceptive injections and skeletal health

By Renner Regina Maria Edelman Alison B Kaunitz Andrew M

Women's Health, Vol. 6, Iss. 3, 2010-05 ,pp. : 339-342

Future Medicine

Access to resources Recommend Favorite

Comparative effectiveness of fingolimod versus interferons or glatiramer acetate for relapse rates in multiple sclerosis: a retrospective US claims database analysis

By Bergvall Niklas Makin Charles Lahoz Raquel Agashivala Neetu Pradhan Ashish Capkun Gorana Petrilla Allison Karkare Swapna U. Balderston McGuiness Catherine Korn Jonathan R.

Current Medical Research and Opinion, Vol. 29, Iss. 12, 2013-12 ,pp. : 1647-1656

Informa Healthcare

Access to resources Recommend Favorite

Cost‐effectiveness of continuous subcutaneous insulin infusion versus multiple daily injections of insulin in Type 1 diabetes: a systematic review

DIABETIC MEDICINE, Vol. 32, Iss. 11, 2015-11 ,pp. : 1415-1424

John Wiley & Sons Inc

Access to resources Recommend Favorite